Trial Outcomes & Findings for Targeting Personalized Brain States Reflecting Strong and Weak Corticospinal Tract Output in Real-time (NCT NCT06365086)
NCT ID: NCT06365086
Last Updated: 2025-04-17
Results Overview
Peak-to-peak MEP amplitudes elicited by single transcranial magnetic stimulation (TMS) pulses delivered during personalized strong and weak CST states will be measured from the left first dorsal interosseous muscle. At the individual participant level, all MEP amplitudes will be normalized to the mean MEP amplitude observed in that participant. Mean normalized MEP amplitudes will be compared across CST states.
COMPLETED
NA
21 participants
single session
2025-04-17
Participant Flow
There were no specific pre-assignment procedures or events for this study.
Participant milestones
| Measure |
Healthy Adults
Healthy adults first had single-pulse TMS delivered to the right motor cortex irrespective of ongoing brain activity (i.e., brain states) in order to generate a training dataset that included brain activity recordings and muscle responses to TMS delivery.
Then, this training dataset was used to build a personalized mathematical model that discriminated between brain activity patterns reflecting strong and weak corticospinal tract (CST) activation (i.e., strong and weak CST states).
After building this model, participants received single-pulse TMS to the right motor cortex during personalized brain states reflecting strong corticospinal tract (CST) activation (strong CST states), weak CST states, and random CST states. Stimulation was delivered at 120% of resting motor threshold and motor-evoked potentials (MEPs) were recorded from the left first dorsal interosseous muscle.
|
|---|---|
|
Training Phase
STARTED
|
21
|
|
Training Phase
COMPLETED
|
21
|
|
Training Phase
NOT COMPLETED
|
0
|
|
Testing Phase
STARTED
|
21
|
|
Testing Phase
Strong CST States
|
21
|
|
Testing Phase
Weak CST States
|
21
|
|
Testing Phase
Random CST States
|
21
|
|
Testing Phase
COMPLETED
|
21
|
|
Testing Phase
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Targeting Personalized Brain States Reflecting Strong and Weak Corticospinal Tract Output in Real-time
Baseline characteristics by cohort
| Measure |
Healthy Adults
n=19 Participants
Healthy adults received single-pulse TMS the right motor cortex during personalized brain states reflecting strong corticospinal tract (CST) activation (strong CST states), weak CST states, and random CST states. Stimulation was delivered at 120% of resting motor threshold and motor-evoked potentials (MEPs) were recorded from the left first dorsal interosseous muscle.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
19 Participants
n=99 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=99 Participants
|
|
Age, Continuous
|
20.8 years
STANDARD_DEVIATION 3.05 • n=99 Participants
|
|
Sex: Female, Male
Female
|
15 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
4 Participants
n=99 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
2 Participants
n=99 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
11 Participants
n=99 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
6 Participants
n=99 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Asian
|
8 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
White
|
1 Participants
n=99 Participants
|
|
Race (NIH/OMB)
More than one race
|
3 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
7 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
19 Participants
n=99 Participants
|
PRIMARY outcome
Timeframe: single sessionPeak-to-peak MEP amplitudes elicited by single transcranial magnetic stimulation (TMS) pulses delivered during personalized strong and weak CST states will be measured from the left first dorsal interosseous muscle. At the individual participant level, all MEP amplitudes will be normalized to the mean MEP amplitude observed in that participant. Mean normalized MEP amplitudes will be compared across CST states.
Outcome measures
| Measure |
Strong CST States
n=19 Participants
Normalized MEPs elicited during strong CST states were calculated.
|
Weak CST States
n=19 Participants
Normalized MEPs elicited during weak CST states were calculated.
|
Random CST States
n=19 Participants
Normalized MEPs elicited during random CST states were calculated.
|
|---|---|---|---|
|
Motor-evoked Potential (MEP) Amplitudes
|
1.13 arbitrary units (normalized microvolts)
Standard Error 0.05
|
0.96 arbitrary units (normalized microvolts)
Standard Error 0.04
|
0.90 arbitrary units (normalized microvolts)
Standard Error 0.05
|
SECONDARY outcome
Timeframe: single sessionAn offline version of the real-time EEG analysis algorithm will be used to determine the brain state (i.e., strong or weak CST states, or neither) immediately preceding delivery of each single TMS pulse. The proportion of trials during which the online and offline versions of the real-time EEG analysis algorithm produce the same brain state prediction will be calculated per participant and used as a state-targeting accuracy metric. State-targeting accuracy metrics will be compared to the theoretical chance level (0.5).
Outcome measures
| Measure |
Strong CST States
n=19 Participants
Normalized MEPs elicited during strong CST states were calculated.
|
Weak CST States
n=19 Participants
Normalized MEPs elicited during weak CST states were calculated.
|
Random CST States
n=19 Participants
Normalized MEPs elicited during random CST states were calculated.
|
|---|---|---|---|
|
State-targeting Accuracy
|
94.5 percentage of trials accurately targeted
Standard Error 1.1
|
89.5 percentage of trials accurately targeted
Standard Error 2.7
|
NA percentage of trials accurately targeted
Standard Error NA
Due to the nature of this condition, the ability of our real-time system to accurately target random CST states cannot be calculated.
|
Adverse Events
Healthy Adults
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place